CS Genetics
Developing a disruptive platform for single-cell genomics using instrument-free, solution-phase chemical biology for highly scalable and accessible single-cell analysis.
Website
https://www.csgenetics.com/Location
Cambridge, UK
Founded
2019
Investors
1
Categories
genomics, single-cell, biotechnology, sequencing
Notes
CS Genetics is a Cambridge, UK-based biotechnology company developing a disruptive platform for single-cell genomics. The company's technology leverages instrument-free, solution-phase chemical biology, which offers potential advantages in scalability and accessibility compared to traditional microfluidics-based approaches.
The company's approach aims to democratize single-cell analysis by removing the need for specialized instrumentation, potentially making the technology more accessible to a broader range of research laboratories and clinical applications.
Team
- Shankar Balasubramanian - Co-founder (FRS, Professor at University of Cambridge, co-inventor of Solexa/Illumina sequencing)
- Tuval Ben-Yehezkel - Co-founder & CEO
Additional Research Findings
- Founded by pioneers in DNA sequencing technology
- Instrument-free approach using chemical biology
- Focused on making single-cell genomics more accessible and scalable
- Based in Cambridge, UK life sciences cluster
- Addresses limitations of current microfluidics-based single-cell technologies
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| AlbionVC (Healthcare) | London, UK | biotech-focused | seedseries-a+1 | 17 |